Literature DB >> 23335049

Management of distal rectal cancer: results from a national survey.

G Melotti1, E De Antoni, A Habr-Gama, A Minicozzi.   

Abstract

Owing to the complexity of distal rectal cancer its management requires a multidisciplinary approach. The diagnosis and the response after neoadjuvant chemoradiotherapy are not easy to assess and therefore the surgical approach is heterogeneous. The purpose of this survey is to evaluate the experiences of members of the Italian Society of Surgery in diagnosis and treatment strategies for rectal cancer and compare it with international practice. A questionnaire was devised comprising 18 questions with 11 sub-items making a total of 29 questions and submitted online to all the 2,500 members of the SIC starting from July 2010. The survey was completed in June 2011. The overall response rate was 17.8 % (444). The majority of the Italian surgeons' responses were in line with the international consensus reflecting the complex management of distal rectal cancer. Other opinions, especially those on staging, diverge from the common view of MRI being the gold standard in the assessment of loco-regional diffusion of the disease and on the superiority of FDG PET-CT versus CT for systemic staging. The timing for the re-staging and for surgery following neoadjuvant chemoradiotherapy does not reflect the international opinion. Italian surgeons are also exposed to the common difficulties encountered internationally in the management of distal rectal cancer. Probably, the implementation of an Italian rectal cancer registry and of many national and international multicentre studies may improve the management of rectal cancer in Italy.

Entities:  

Mesh:

Year:  2013        PMID: 23335049     DOI: 10.1007/s13304-012-0192-x

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  56 in total

1.  Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision.

Authors:  O C Shihab; P Quirke; R J Heald; B J Moran; G Brown
Journal:  Br J Surg       Date:  2010-09       Impact factor: 6.939

2.  The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.

Authors:  Carlo Capirci; Domenico Rubello; Felice Pasini; Fabrizio Galeotti; Enzo Bianchini; Giuseppe Del Favero; Riccardo Panzavolta; Giorgio Crepaldi; Lucia Rampin; Enzo Facci; Marcello Gava; Elena Banti; Gianfranco Marano
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-04       Impact factor: 7.038

Review 3.  Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  S T Martin; H M Heneghan; D C Winter
Journal:  Br J Surg       Date:  2012-02-23       Impact factor: 6.939

4.  Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Gregory Wynn; John Marks; Hermann Kessler; Joaquim Gama-Rodrigues
Journal:  Dis Colon Rectum       Date:  2010-12       Impact factor: 4.585

5.  Criteria for three-dimensional anorectal ultrasound assessment of response to chemoradiotherapy in rectal cancer patients.

Authors:  S M Murad-Regadas; F S P Regadas; L V Rodrigues; F J Crispin; V T Kenmoti; G O d S Fernandes; G Buchen; F C C Monteiro
Journal:  Colorectal Dis       Date:  2011-12       Impact factor: 3.788

6.  A nationwide audit of the use of radiotherapy for rectal cancer in Italy.

Authors:  G Gagliardi; S Pucciarelli; C R Asteria; A Infantino; G Romano; B Cola; P De Nardi; M Brulatti; M Lambertini; E Contessini-Avesani; G Casula; C Coco; D D'Amico; F F Selvaggi; C Eccher; G D'Ambrosio; F Galeotti; E Jovine; I Demma; A Fianchini; G Ambrosino; L M Casentino; M Fiorino
Journal:  Tech Coloproctol       Date:  2010-07-15       Impact factor: 3.781

7.  Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.

Authors:  Matthew F Kalady; Luiz Felipe de Campos-Lobato; Luca Stocchi; Daniel P Geisler; David Dietz; Ian C Lavery; Victor W Fazio
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

8.  A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy.

Authors:  G Lezoche; M Baldarelli; Mario Guerrieri; A M Paganini; A De Sanctis; S Bartolacci; E Lezoche
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

9.  Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.

Authors:  Jose G Guillem; Harvey G Moore; Timothy Akhurst; David S Klimstra; Leyo Ruo; Madhu Mazumdar; Bruce D Minsky; Leonard Saltz; W Douglas Wong; Steven Larson
Journal:  J Am Coll Surg       Date:  2004-07       Impact factor: 6.113

10.  Regression of rectal cancer with radiotherapy with or without concurrent capecitabine--optimising the timing of surgical resection.

Authors:  A S Dhadda; A M Zaitoun; E M Bessell
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-11-21       Impact factor: 4.126

View more
  2 in total

Review 1.  Consequences of defensive medicine, second victims, and clinical-judicial syndrome on surgeons' medical practice and on health service.

Authors:  Italia Maria Pellino; Gianluca Pellino
Journal:  Updates Surg       Date:  2015-12-09

Review 2.  Prophylactic negative pressure wound therapy in colorectal surgery. Effects on surgical site events: current status and call to action.

Authors:  Gianluca Pellino; Guido Sciaudone; Francesco Selvaggi; Silvestro Canonico
Journal:  Updates Surg       Date:  2015-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.